Hui Xie
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis 10
- Cancer Research top 10%
- Obstetrics and Gynecology top 5%
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 10
- Pancreatic and Hepatic Oncology Research 5
- General Dentistry top 10%
-
- Renal cell carcinoma treatment 7
-
- COVID-19 Clinical Research Studies 5
-
- Respiratory viral infections research 5
- Pneumonia and Respiratory Infections 5
- Liver Disease Diagnosis and Treatment 5
- Journals
- Clinica Chimica Acta (4 papers)Oncotarget (3 papers)International Journal of Infectious Diseases (2 papers)
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Hui Xie
88 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 121
- Hepatology 275
- Cancer Research 210
- Obstetrics and Gynecology 109
- Oncology 379
- General Dentistry 18
Countries citing papers authored by Hui Xie
This map shows the geographic impact of Hui Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Xie more than expected).
Fields of papers citing papers by Hui Xie
This network shows the impact of papers produced by Hui Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Xie. The network helps show where Hui Xie may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hui Xie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 6 | |
| 3 | 2024 | 8 | |
| 4 | 2023 | 4 | |
| 5 | 2022 | 6 | |
| 6 | 2021 | 2 | |
| 7 | 2021 | 4 | |
| 8 | 2020 | 24 | |
| 9 | 2019 | 56 | |
| 10 | 2018 | 42 | |
| 11 | 2018 | 44 | |
| 12 | 2017 | 13 | |
| 13 | Systematic review on the efficacy and safety of kidney-tonifying and blood-activating medicine for knee osteoarthritis | 2016 | 1 |
| 14 | Taijiquan for osteoarthritis: A systematic review and Meta-analysis | 2016 | 2 |
| 15 | 2016 | 3 | |
| 16 | 2016 | 45 | |
| 17 | 2014 | 30 | |
| 18 | 2013 | 4 | |
| 19 | 2012 | 2 | |
| 20 | Clinical observation on the therapeutic effect of methylprednisolone on babies with pneumonia | 2005 | 1 |
About Hui Xie
Hui Xie is a scholar working on Hepatology, Internal Medicine and Microbiology, having authored 95 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (10 papers), Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Renal cell carcinoma treatment (7 papers), Pancreatic and Hepatic Oncology Research (5 papers), COVID-19 Clinical Research Studies (5 papers), Respiratory viral infections research (5 papers), Pneumonia and Respiratory Infections (5 papers) and Liver Disease Diagnosis and Treatment (5 papers). The work is most often cited by research in Hepatology (275 citations), Cancer Research (210 citations) and Obstetrics and Gynecology (109 citations). Hui Xie has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Huaming Wang, Yinying Lu, Yongping Yang, Zhun Wang, Shuanghe Peng, Xudong Gao, Ruilan Wang, Yun Zhao, Jing Peng and Hui Yang. Their work appears in journals such as Clinica Chimica Acta, Oncotarget, International Journal of Infectious Diseases, Cancer Medicine and Trials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.